NOS2 and cystic fibrosis: Studies in CF have previously demonstrated increased arginase activity, increased concentrations of the endogenous NOS inhibitors asymmetric dimethylarginine (ADMA) and spermine, reduced L-arginine availability for NOS, and reduced NO formation in CF airways [19, 28–32].